Zoetis Company Insiders
ZTS Stock | USD 157.52 7.41 4.49% |
Zoetis' insiders are aggressively selling. The analysis of insiders' sentiment of trading Zoetis Inc stock suggests that vertually all insiders are panicking at this time. Zoetis employs about 14.1 K people. The company is managed by 37 executives with a total tenure of roughly 210 years, averaging almost 5.0 years of service per executive, having 381.08 employees per reported executive.
Kristin Peck CEO Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director |
Juan Alaix CEO Chief Executive Officer, Director |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-02-11 | Roxanne Lagano | Disposed 326 @ 171.18 | View | ||
2024-07-05 | Jared Moskowitz | Disposed @ 174.96 | |||
2024-04-18 | Roxanne Lagano | Disposed 923 @ 151.17 | View | ||
2024-04-03 | Markwayne Mullin | Disposed @ 162.94 | |||
2024-03-18 | Roxanne Lagano | Disposed 923 @ 173.33 | View |
Monitoring Zoetis' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Zoetis |
Zoetis' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Zoetis' future performance. Based on our forecasts, it is anticipated that Zoetis will maintain a workforce of slightly above 14100 employees by March 2025.Zoetis' latest congressional trading
Congressional trading in companies like Zoetis Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zoetis by those in governmental positions are based on the same information available to the general public.
2024-08-19 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
2024-08-06 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
2024-05-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-04-30 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-03-15 | Senator Shelley Moore Capito | Acquired $15K to $50K | Verify | ||
2024-03-14 | Senator Shelley Moore Capito | Acquired $15K to $50K | Verify | ||
2024-01-26 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2024-01-25 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify |
Zoetis Management Team Effectiveness
The company has Return on Asset of 0.1487 % which means that on every $100 spent on assets, it made $0.1487 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5114 %, implying that it generated $0.5114 on every 100 dollars invested. Zoetis' management efficiency ratios could be used to measure how well Zoetis manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Zoetis' Return On Capital Employed is comparatively stable compared to the past year. Return On Assets is likely to gain to 0.18 in 2025, whereas Return On Tangible Assets are likely to drop 0.12 in 2025. At this time, Zoetis' Non Currrent Assets Other are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 1.4 B in 2025, whereas Non Current Assets Total are likely to drop slightly above 5.9 B in 2025.Net Income Applicable To Common Shares is likely to gain to about 2.6 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 387.6 M in 2025.
Zoetis Workforce Comparison
Zoetis Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 212,203. Zoetis holds roughly 14,100 in number of employees claiming about 7% of equities under Health Care industry.
Zoetis Profit Margins
The company has Net Profit Margin of 0.27 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.33 %, which entails that for every 100 dollars of revenue, it generated $0.33 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.53 | 0.7062 |
|
| |||||
Operating Profit Margin | 0.71 | 0.6755 |
|
| |||||
Return On Assets | 0.18 | 0.1746 |
|
| |||||
Return On Equity | 0.33 | 0.5212 |
|
|
Zoetis Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zoetis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zoetis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zoetis insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 0.6456 | 51 | 79 | 65,055 | 84,116 |
2024-12-01 | 3.3333 | 10 | 3 | 4,703 | 6,954 |
2024-09-01 | 2.5 | 10 | 4 | 4,329 | 18,056 |
2024-06-01 | 1.625 | 13 | 8 | 35,910 | 44,345 |
2024-03-01 | 1.125 | 108 | 96 | 317,311 | 163,215 |
2023-12-01 | 0.8462 | 11 | 13 | 16,224 | 45,206 |
2023-09-01 | 1.1818 | 13 | 11 | 18,110 | 40,523 |
2023-06-01 | 0.9 | 9 | 10 | 19,387 | 45,312 |
2023-03-01 | 3.8148 | 103 | 27 | 344,058 | 55,007 |
2022-12-01 | 2.5 | 10 | 4 | 1,822 | 12,212 |
2022-09-01 | 2.0 | 18 | 9 | 13,625 | 26,171 |
2022-06-01 | 1.8571 | 13 | 7 | 7,321 | 15,736 |
2022-03-01 | 1.5789 | 90 | 57 | 426,955 | 278,909 |
2021-12-01 | 0.8235 | 14 | 17 | 35,585 | 90,513 |
2021-09-01 | 1.0 | 14 | 14 | 31,311 | 84,309 |
2021-06-01 | 1.0385 | 27 | 26 | 96,512 | 127,671 |
2021-03-01 | 1.4304 | 113 | 79 | 1,070,375 | 1,215,929 |
2020-12-01 | 1.0588 | 18 | 17 | 23,083 | 137,404 |
2020-09-01 | 0.9474 | 18 | 19 | 25,229 | 65,614 |
2020-06-01 | 1.1333 | 17 | 15 | 25,959 | 53,818 |
2020-03-01 | 1.0816 | 106 | 98 | 1,154,649 | 1,504,148 |
2019-12-01 | 0.7742 | 24 | 31 | 156,609 | 328,763 |
2019-09-01 | 1.125 | 18 | 16 | 32,005 | 66,655 |
2019-06-01 | 1.0588 | 18 | 17 | 67,413 | 136,457 |
2019-03-01 | 1.4203 | 98 | 69 | 1,282,005 | 1,183,609 |
2018-12-01 | 1.1667 | 14 | 12 | 164,591 | 351,612 |
2018-09-01 | 1.2308 | 16 | 13 | 209,389 | 420,271 |
2018-06-01 | 3.6667 | 11 | 3 | 12,549 | 8,789 |
2018-03-01 | 1.375 | 99 | 72 | 1,101,154 | 843,514 |
2017-09-01 | 2.3333 | 14 | 6 | 18,357 | 14,505 |
2017-06-01 | 6.0 | 12 | 2 | 14,077 | 20,598 |
2017-03-01 | 3.625 | 58 | 16 | 722,788 | 229,522 |
2016-12-01 | 9.0 | 18 | 2 | 47,860 | 19,889 |
2016-09-01 | 1.25 | 25 | 20 | 125,723 | 199,397 |
2016-06-01 | 10.0 | 10 | 1 | 13,446 | 16,850,000 |
2016-03-01 | 3.7857 | 53 | 14 | 786,310 | 216,905 |
2015-12-01 | 3.0 | 12 | 4 | 25,312 | 27,269 |
2015-09-01 | 13.0 | 13 | 1 | 1,552,031 | 1,540,713 |
2015-06-01 | 3.0 | 9 | 3 | 7,136 | 41,658 |
2015-03-01 | 3.875 | 31 | 8 | 225,082 | 30,304 |
2014-03-01 | 5.0 | 45 | 9 | 386,317 | 13,423 |
Zoetis Notable Stakeholders
A Zoetis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zoetis often face trade-offs trying to please all of them. Zoetis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zoetis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kristin Peck | Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director | Profile | |
Juan Alaix | Chief Executive Officer, Director | Profile | |
Michael McCallister | Non-Executive Independent Chairman of the Board | Profile | |
Roman Trawicki | Executive Vice President and Presidentident of Global Manufacturing and Supply | Profile | |
Roxanne Lagano | Chief Human Resource Officer, Executive Vice President and Global Operations | Profile | |
Sherry Pudloski | Executive Vice President - Corporate Affairs and Communications | Profile | |
Catherine Knupp | Executive Vice President, President - Research and Development | Profile | |
Glenn David | Chief Financial Officer, Executive Vice President | Profile | |
Wetteny Joseph | Chief Financial Officer, Executive Vice President, Head of Business Development | Profile | |
Heidi Chen | Executive Vice President General Counsel, Corporate Secretary | Profile | |
Wetteny CPA | Executive CFO | Profile | |
William Steere | Independent Director | Profile | |
Linda Rhodes | Independent Director | Profile | |
Frank DAmelio | Independent Director | Profile | |
Robert Scully | Independent Director | Profile | |
Sanjay Khosla | Independent Director | Profile | |
Paul Bisaro | Independent Director | Profile | |
Antoinette Leatherberry | Independent Director | Profile | |
Willie Reed | Independent Director | Profile | |
Gregory Norden | Independent Director | Profile | |
Louise Parent | Independent Director | Profile | |
Julie Fuller | Chief VP | Profile | |
Steven Frank | Vice Relations | Profile | |
Wafaa Mamilli | Executive Vice President and Chief Information and Digital Officer | Profile | |
Timothy Bettington | Executive Vice President and President U.S. Operations | Profile | |
Ester Banque | Executive Operations | Profile | |
William Price | VP Officer | Profile | |
Jamie Brannan | Executive Diagnostics | Profile | |
Jeannette Astorga | Executive Officer | Profile | |
Nick Ashton | Executive Supply | Profile | |
William Dorsey | Vice Diagnostics | Profile | |
Rimma Driscoll | Commercial Strategy | Profile | |
Robert Kelly | Executive Vice President and President International Operations | Profile | |
J McFarland | Executive Vice President and Chief Medical Officer | Profile | |
Keith Sarbaugh | Executive Officer | Profile | |
Robert Polzer | Executive Vice President and Presidentident of Research and Development | Profile | |
Abhay Nayak | Executive Vice President Head of Strategy and Accelerated Growth Businesses | Profile |
About Zoetis Management Performance
The success or failure of an entity such as Zoetis Inc often depends on how effective the management is. Zoetis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zoetis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zoetis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.24 | 0.12 | |
Return On Capital Employed | 0.58 | 0.61 | |
Return On Assets | 0.17 | 0.18 | |
Return On Equity | 0.52 | 0.33 |
Please note, the imprecision that can be found in Zoetis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zoetis Inc. Check Zoetis' Beneish M Score to see the likelihood of Zoetis' management manipulating its earnings.
Zoetis Workforce Analysis
Traditionally, organizations such as Zoetis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zoetis within its industry.Zoetis Manpower Efficiency
Return on Zoetis Manpower
Revenue Per Employee | 656.5K | |
Revenue Per Executive | 250.2M | |
Net Income Per Employee | 177K | |
Net Income Per Executive | 67.5M | |
Working Capital Per Employee | 182.6K | |
Working Capital Per Executive | 69.6M |
Additional Tools for Zoetis Stock Analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.